immunohistochemical images (Human Protein Atlas)
86
Structured Review
Human Protein Atlas
immunohistochemical images
Immunohistochemical Images, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc/images+immunohistochemical/pmc13247677-155-0-5
Average 86 stars, based on 1 article reviews
Immunohistochemical Images, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc/images+immunohistochemical/pmc13247677-155-0-5
Average 86 stars, based on 1 article reviews
immunohistochemical images - by Bioz Stars,
2026-09
86/100 stars
Images
1) Product Images from "LATS2 expression differences in lung adenocarcinoma and lung squamous cell carcinoma analyzed using bioinformatics and experimental approaches"
Article Title: LATS2 expression differences in lung adenocarcinoma and lung squamous cell carcinoma analyzed using bioinformatics and experimental approaches
Journal: Oncology Letters
doi: 10.3892/ol.2026.15671
Figure Legend Snippet: Comprehensive expression analysis of LATS2 in LUAD and LUSC. (A) Expression levels of LATS2 in LUAD and LUSC analyzed using the Gene Set Cancer Analysis platform. (B) Comparative analysis of LATS2 expression between tumor and normal tissues in LUAD using independent sample t-test and paired sample t-test. (C) Comparative analysis of LATS2 expression between tumor and normal tissues in LUSC using independent sample t-test and paired sample t-test. (D) Differential expression of LATS2 between LUAD and LUSC tumor tissues. (E) Immunohistochemical validation of LATS2 expression in LUAD, LUSC and normal lung tissues using the Human Protein Atlas database (antibody ID: 039191). All the data are presented as mean ± SD. ***P<0.001. LATS2, large tumor suppressor kinase 2; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; TPM, transcripts per million; RSEM, RNA-seq by expectation-maximization.
Techniques Used: Expressing, Quantitative Proteomics, Immunohistochemical staining, Biomarker Discovery, RNA Sequencing
Related Articles
other:Article Title: Mediator complex subunit 8 promotes bladder cancer progression via Stearoyl-CoA desaturase Article Snippet: The results demonstrated that MED8 protein was indeed highly expressed in bladder cancer tissues compared to adjacent normal tissues (Fig. G, Fig. B), which was consistent with the IHC results from the Article Title: HSPA6 Promotes Ferroptosis in Triple-Negative Breast Cancer by Rewiring Lipid Metabolism to Potentiate Membrane Lipid Peroxidation Article Snippet: Mechanistically, elevated HSPA6 protein levels in TNBC compared to healthy breast tissues were validated by IHC (Figure J and Figure K), consistent with findings from the Article Title: Mediator complex subunit 8 promotes bladder cancer progression via Stearoyl-CoA desaturase. Article Snippet: Knockdown of MED8 suppresses bladder cancer cell proliferation and migration To delineate MED8’s role in bladder cancer progression, stable MED8-knockdown models were established in T24 and J82 BLCA cell lines (Fig. 3A, Fig. S3A, B). expressed in bladder cancer tissues compared to adjacent normal tissues (Fig. 2G, Fig. S2B), which was consistent with the IHC results from the Article Title: Integrated multi-omics analysis reveals necroptosis-related biomarker BIRC3 for early diagnosis and therapeutic targeting in preeclampsia Article Snippet: Moreover, we confirmed BIRC3 expression via the IHC results provided by the Article Title: TSG101 Promotes SIAH1 Auto-Ubiquitination to Drive Migration and Invasion in Hepatocellular Carcinoma Cells. Article Snippet: Article Title: Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target. Article Snippet: Article Title: ELK1/NOL3/GRP78 axis regulates proliferation and stemness in TP53-mutant colon cancer by enhancing adaptive endoplasmic reticulum stress. Article Snippet: Background: Colon cancer harboring TP53 mutations is highly aggressive and associated with short survival.. Adaptive, rather than apoptotic, endoplasmic reticulum (ER) stress endows TP53-mutant tumor cells with enhanced protein-folding capacity, metabolic plasticity, and chemoresistance.. However, the upstream regulators that selectively drive this cytoprotective program within the cancer stem cell compartment remain elusive. Article Title: Systems Biology Identifies TARS2 as a Cardiomyocyte Regulator of Mitochondrial Oxidative Stress in Dilated Cardiomyopathy Article Snippet: Processed |
